nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamerazine—ALB—Abiraterone—prostate cancer	0.378	0.401	CbGbCtD
Sulfamerazine—ALB—Estrone—prostate cancer	0.273	0.29	CbGbCtD
Sulfamerazine—ALB—Estradiol—prostate cancer	0.157	0.166	CbGbCtD
Sulfamerazine—ALB—Prednisone—prostate cancer	0.135	0.143	CbGbCtD
Sulfamerazine—Sulfamethoxazole—NAT1—prostate cancer	0.0039	0.327	CrCbGaD
Sulfamerazine—Sulfamethoxazole—NAT2—prostate cancer	0.00123	0.103	CrCbGaD
Sulfamerazine—Sulfathiazole—CYP19A1—prostate cancer	0.00111	0.0933	CrCbGaD
Sulfamerazine—Dapsone—NAT2—prostate cancer	0.000961	0.0805	CrCbGaD
Sulfamerazine—Dapsone—CYP2C18—prostate cancer	0.000611	0.0512	CrCbGaD
Sulfamerazine—Sulfaphenazole—CYP2A6—prostate cancer	0.000588	0.0492	CrCbGaD
Sulfamerazine—Sulfadiazine—CYP2E1—prostate cancer	0.000456	0.0382	CrCbGaD
Sulfamerazine—Dapsone—MPO—prostate cancer	0.000455	0.0381	CrCbGaD
Sulfamerazine—Dapsone—CYP3A5—prostate cancer	0.000402	0.0337	CrCbGaD
Sulfamerazine—Sulfanilamide—CYP2E1—prostate cancer	0.00031	0.026	CrCbGaD
Sulfamerazine—Sulfanilamide—CYP2C19—prostate cancer	0.000307	0.0257	CrCbGaD
Sulfamerazine—Sulfadiazine—CYP3A4—prostate cancer	0.000287	0.0241	CrCbGaD
Sulfamerazine—Dapsone—CYP2E1—prostate cancer	0.000276	0.0232	CrCbGaD
Sulfamerazine—Dapsone—CYP2C19—prostate cancer	0.000274	0.0229	CrCbGaD
Sulfamerazine—Sulfamethoxazole—CYP3A4—prostate cancer	0.000223	0.0186	CrCbGaD
Sulfamerazine—Sulfanilamide—CYP3A4—prostate cancer	0.000195	0.0163	CrCbGaD
Sulfamerazine—Dapsone—CYP3A4—prostate cancer	0.000174	0.0146	CrCbGaD
Sulfamerazine—Dapsone—PTGS2—prostate cancer	0.00017	0.0143	CrCbGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CBR1—prostate cancer	0.000158	0.00356	CbGpPWpGaD
Sulfamerazine—ALB—Vitamin B12 Metabolism—SERPINE1—prostate cancer	0.000157	0.00355	CbGpPWpGaD
Sulfamerazine—ALB—Response to elevated platelet cytosolic Ca2+—ITGB3—prostate cancer	0.000154	0.00346	CbGpPWpGaD
Sulfamerazine—ALB—Folate Metabolism—ICAM1—prostate cancer	0.000153	0.00346	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—CLU—prostate cancer	0.000153	0.00344	CbGpPWpGaD
Sulfamerazine—ALB—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.00015	0.00339	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00015	0.00338	CbGpPWpGaD
Sulfamerazine—ALB—Folate Metabolism—INS—prostate cancer	0.000139	0.00314	CbGpPWpGaD
Sulfamerazine—ALB—Selenium Micronutrient Network—MTHFR—prostate cancer	0.000139	0.00314	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	0.000138	0.00311	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—GNG5—prostate cancer	0.000133	0.003	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—STX4—prostate cancer	0.000131	0.00296	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—RAD51B—prostate cancer	0.000131	0.00296	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	0.000131	0.00295	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	0.000131	0.00295	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	0.000131	0.00295	CbGpPWpGaD
Sulfamerazine—ALB—Folate Metabolism—SERPINE1—prostate cancer	0.000128	0.00289	CbGpPWpGaD
Sulfamerazine—ALB—Platelet degranulation—EGF—prostate cancer	0.000125	0.00281	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.000125	0.00281	CbGpPWpGaD
Sulfamerazine—ALB—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000123	0.00277	CbGpPWpGaD
Sulfamerazine—ALB—Selenium Micronutrient Network—ICAM1—prostate cancer	0.000122	0.00275	CbGpPWpGaD
Sulfamerazine—ALB—Response to elevated platelet cytosolic Ca2+—EGF—prostate cancer	0.000119	0.00268	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000119	0.00268	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—F9—prostate cancer	0.000118	0.00267	CbGpPWpGaD
Sulfamerazine—ALB—Platelet degranulation—IGF1—prostate cancer	0.000116	0.00261	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.000111	0.00251	CbGpPWpGaD
Sulfamerazine—ALB—Selenium Micronutrient Network—INS—prostate cancer	0.000111	0.0025	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—THBS1—prostate cancer	0.00011	0.00249	CbGpPWpGaD
Sulfamerazine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—prostate cancer	0.00011	0.00248	CbGpPWpGaD
Sulfamerazine—ALB—Platelet degranulation—SERPINE1—prostate cancer	0.00011	0.00248	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—PRKCZ—prostate cancer	0.000107	0.00241	CbGpPWpGaD
Sulfamerazine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—prostate cancer	0.000105	0.00236	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.000105	0.00236	CbGpPWpGaD
Sulfamerazine—ALB—Folate Metabolism—IL2—prostate cancer	0.000104	0.00234	CbGpPWpGaD
Sulfamerazine—ALB—Selenium Micronutrient Network—SERPINE1—prostate cancer	0.000102	0.00229	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.000102	0.00229	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	9.91e-05	0.00224	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—CYP7B1—prostate cancer	9.67e-05	0.00218	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	9.45e-05	0.00213	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	9.45e-05	0.00213	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—SLC12A2—prostate cancer	9.42e-05	0.00213	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—SLC26A4—prostate cancer	9.42e-05	0.00213	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—ITGA6—prostate cancer	9.26e-05	0.00209	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—PRKCQ—prostate cancer	9.08e-05	0.00205	CbGpPWpGaD
Sulfamerazine—ALB—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	8.95e-05	0.00202	CbGpPWpGaD
Sulfamerazine—ALB—Selenium Micronutrient Network—PTGS2—prostate cancer	8.88e-05	0.002	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—CD9—prostate cancer	8.7e-05	0.00196	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—HAO1—prostate cancer	8.62e-05	0.00194	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—VAV3—prostate cancer	8.33e-05	0.00188	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	8.07e-05	0.00182	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	8.04e-05	0.00181	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—CLU—prostate cancer	7.87e-05	0.00178	CbGpPWpGaD
Sulfamerazine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	7.77e-05	0.00175	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	7.71e-05	0.00174	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—SLC22A3—prostate cancer	7.64e-05	0.00172	CbGpPWpGaD
Sulfamerazine—ALB—Platelet degranulation—VEGFA—prostate cancer	7.55e-05	0.0017	CbGpPWpGaD
Sulfamerazine—ALB—Vitamin B12 Metabolism—IL6—prostate cancer	7.49e-05	0.00169	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	7.42e-05	0.00167	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—GRB7—prostate cancer	7.2e-05	0.00162	CbGpPWpGaD
Sulfamerazine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	7.19e-05	0.00162	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	7.17e-05	0.00162	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	7.15e-05	0.00161	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—ABCG5—prostate cancer	7.05e-05	0.00159	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CSAD—prostate cancer	7.03e-05	0.00159	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GRHL1—prostate cancer	7.03e-05	0.00159	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PSAT1—prostate cancer	7.03e-05	0.00159	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CBR1—prostate cancer	7.03e-05	0.00159	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—TST—prostate cancer	7.03e-05	0.00159	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—ADI1—prostate cancer	7.03e-05	0.00159	CbGpPWpGaD
Sulfamerazine—ALB—Platelet degranulation—TGFB1—prostate cancer	6.93e-05	0.00156	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	6.87e-05	0.00155	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—GNG5—prostate cancer	6.85e-05	0.00154	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	6.74e-05	0.00152	CbGpPWpGaD
Sulfamerazine—ALB—Folate Metabolism—TP53—prostate cancer	6.65e-05	0.0015	CbGpPWpGaD
Sulfamerazine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	6.6e-05	0.00149	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GRHPR—prostate cancer	6.53e-05	0.00147	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CKMT2—prostate cancer	6.53e-05	0.00147	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—UGT2B15—prostate cancer	6.53e-05	0.00147	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—UGT2B17—prostate cancer	6.53e-05	0.00147	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	6.39e-05	0.00144	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—MED12—prostate cancer	6.28e-05	0.00142	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.23e-05	0.00141	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—AOX1—prostate cancer	6.14e-05	0.00139	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—MBTPS1—prostate cancer	6.14e-05	0.00139	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—NAGLU—prostate cancer	6.14e-05	0.00139	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—RFK—prostate cancer	6.14e-05	0.00139	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTM3—prostate cancer	6.14e-05	0.00139	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PGAM2—prostate cancer	6.14e-05	0.00139	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SULT2B1—prostate cancer	6.14e-05	0.00139	CbGpPWpGaD
Sulfamerazine—ALB—Folate Metabolism—IL6—prostate cancer	6.09e-05	0.00137	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	6e-05	0.00135	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—GNG5—prostate cancer	5.93e-05	0.00134	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PRKACB—prostate cancer	5.84e-05	0.00132	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP3A43—prostate cancer	5.82e-05	0.00131	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—AMACR—prostate cancer	5.82e-05	0.00131	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SRD5A2—prostate cancer	5.82e-05	0.00131	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—NAT1—prostate cancer	5.82e-05	0.00131	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—DEGS1—prostate cancer	5.82e-05	0.00131	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	5.73e-05	0.00129	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	5.69e-05	0.00128	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—THBS1—prostate cancer	5.69e-05	0.00128	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	5.6e-05	0.00126	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—HSD17B1—prostate cancer	5.56e-05	0.00125	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	5.56e-05	0.00125	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—EGF—prostate cancer	5.54e-05	0.00125	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PRKCZ—prostate cancer	5.5e-05	0.00124	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	5.34e-05	0.0012	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	5.31e-05	0.0012	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	5.26e-05	0.00119	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—IGF1—prostate cancer	5.13e-05	0.00116	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.05e-05	0.00114	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	5.01e-05	0.00113	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—HPGD—prostate cancer	4.95e-05	0.00112	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—B4GALT4—prostate cancer	4.95e-05	0.00112	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	4.92e-05	0.00111	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	4.87e-05	0.0011	CbGpPWpGaD
Sulfamerazine—ALB—Selenium Micronutrient Network—IL6—prostate cancer	4.84e-05	0.00109	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.77e-05	0.00107	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PRKCQ—prostate cancer	4.68e-05	0.00106	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—TNFRSF21—prostate cancer	4.66e-05	0.00105	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PLAUR—prostate cancer	4.62e-05	0.00104	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.55e-05	0.00103	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—MTAP—prostate cancer	4.53e-05	0.00102	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP7B1—prostate cancer	4.53e-05	0.00102	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—JAK2—prostate cancer	4.52e-05	0.00102	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	4.43e-05	0.000998	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SULT1E1—prostate cancer	4.41e-05	0.000995	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SRD5A1—prostate cancer	4.41e-05	0.000995	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—VAV3—prostate cancer	4.29e-05	0.000968	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	4.29e-05	0.000968	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	4.29e-05	0.000967	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	4.22e-05	0.000952	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—ACSL4—prostate cancer	4.21e-05	0.00095	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—HSD17B3—prostate cancer	4.21e-05	0.00095	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—ITPR1—prostate cancer	4.16e-05	0.000939	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	4.16e-05	0.000939	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—ARG2—prostate cancer	4.04e-05	0.00091	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PHGDH—prostate cancer	4.04e-05	0.00091	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—UMPS—prostate cancer	4.04e-05	0.00091	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	4.02e-05	0.000906	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.02e-05	0.000906	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—LDHB—prostate cancer	3.96e-05	0.000893	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—IL2—prostate cancer	3.94e-05	0.000889	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP3A5—prostate cancer	3.89e-05	0.000876	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—RXRA—prostate cancer	3.82e-05	0.000861	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PDHA1—prostate cancer	3.75e-05	0.000846	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTA3—prostate cancer	3.75e-05	0.000846	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—UCP3—prostate cancer	3.75e-05	0.000846	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—TCN2—prostate cancer	3.75e-05	0.000846	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—ITGB3—prostate cancer	3.69e-05	0.000831	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SLC22A3—prostate cancer	3.58e-05	0.000807	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—HSD3B1—prostate cancer	3.58e-05	0.000807	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.47e-05	0.000783	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	3.44e-05	0.000775	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTA4—prostate cancer	3.43e-05	0.000774	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—TBXAS1—prostate cancer	3.43e-05	0.000774	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.35e-05	0.000757	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	3.35e-05	0.000755	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTA2—prostate cancer	3.34e-05	0.000754	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SULT1A1—prostate cancer	3.3e-05	0.000745	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—ABCG5—prostate cancer	3.3e-05	0.000745	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PLAU—prostate cancer	3.24e-05	0.000732	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTA1—prostate cancer	3.23e-05	0.000728	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—HSD3B2—prostate cancer	3.19e-05	0.00072	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—NAT2—prostate cancer	3.19e-05	0.00072	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTO1—prostate cancer	3.19e-05	0.00072	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—CAV1—prostate cancer	3.17e-05	0.000715	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	3.07e-05	0.000693	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.07e-05	0.000692	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—LRP2—prostate cancer	3.06e-05	0.00069	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP2C18—prostate cancer	3.06e-05	0.00069	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PLCB2—prostate cancer	3.06e-05	0.00069	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—P4HB—prostate cancer	3e-05	0.000677	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SLC22A1—prostate cancer	2.92e-05	0.000658	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	2.92e-05	0.000658	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PIK3CG—prostate cancer	2.89e-05	0.000651	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.88e-05	0.000651	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—EGF—prostate cancer	2.85e-05	0.000643	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SULT2A1—prostate cancer	2.84e-05	0.000641	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—MED12—prostate cancer	2.8e-05	0.000631	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GNG5—prostate cancer	2.78e-05	0.000626	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—CREBBP—prostate cancer	2.68e-05	0.000604	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—NCOA3—prostate cancer	2.67e-05	0.000603	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—IGF1—prostate cancer	2.64e-05	0.000596	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.63e-05	0.000593	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	2.62e-05	0.00059	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—HPGDS—prostate cancer	2.55e-05	0.000575	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PIK3CD—prostate cancer	2.54e-05	0.000572	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP2C19—prostate cancer	2.54e-05	0.000572	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—SERPINE1—prostate cancer	2.51e-05	0.000566	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTT1—prostate cancer	2.47e-05	0.000558	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—ACHE—prostate cancer	2.47e-05	0.000558	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP2A6—prostate cancer	2.45e-05	0.000552	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.44e-05	0.000549	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—NOS3—prostate cancer	2.4e-05	0.00054	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—AKR1C3—prostate cancer	2.38e-05	0.000537	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PRKACB—prostate cancer	2.37e-05	0.000534	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP17A1—prostate cancer	2.34e-05	0.000528	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—JAK2—prostate cancer	2.33e-05	0.000525	CbGpPWpGaD
Sulfamerazine—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.32e-05	0.000522	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.31e-05	0.000521	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—NCOA2—prostate cancer	2.23e-05	0.000503	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PIK3CB—prostate cancer	2.21e-05	0.000499	CbGpPWpGaD
Sulfamerazine—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	2.14e-05	0.000482	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—SLC5A5—prostate cancer	2.13e-05	0.00048	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP2E1—prostate cancer	2.08e-05	0.000469	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—NQO1—prostate cancer	2.06e-05	0.000464	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—IL2—prostate cancer	2.03e-05	0.000458	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—TH—prostate cancer	2.03e-05	0.000457	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.01e-05	0.000454	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP3A4—prostate cancer	2.01e-05	0.000452	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2e-05	0.00045	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP1B1—prostate cancer	1.97e-05	0.000445	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GGT1—prostate cancer	1.91e-05	0.000431	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—NCOA1—prostate cancer	1.88e-05	0.000424	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP19A1—prostate cancer	1.85e-05	0.000418	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—EP300—prostate cancer	1.82e-05	0.000411	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—RXRA—prostate cancer	1.79e-05	0.000403	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—SRC—prostate cancer	1.77e-05	0.0004	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.74e-05	0.000392	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—VEGFA—prostate cancer	1.73e-05	0.000389	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—COMT—prostate cancer	1.72e-05	0.000389	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTP1—prostate cancer	1.72e-05	0.000387	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—ITPR1—prostate cancer	1.69e-05	0.000381	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.66e-05	0.000374	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—TYMS—prostate cancer	1.59e-05	0.00036	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—TGFB1—prostate cancer	1.58e-05	0.000357	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—GSTM1—prostate cancer	1.58e-05	0.000355	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—LPL—prostate cancer	1.55e-05	0.000349	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CYP1A1—prostate cancer	1.49e-05	0.000337	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—ERCC2—prostate cancer	1.48e-05	0.000334	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—KRAS—prostate cancer	1.47e-05	0.000331	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—MTHFR—prostate cancer	1.39e-05	0.000314	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PPARA—prostate cancer	1.37e-05	0.000308	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—PIK3CA—prostate cancer	1.35e-05	0.000304	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—TP53—prostate cancer	1.3e-05	0.000294	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CAV1—prostate cancer	1.28e-05	0.00029	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.23e-05	0.000277	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PIK3CG—prostate cancer	1.17e-05	0.000264	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—INS—prostate cancer	1.11e-05	0.00025	CbGpPWpGaD
Sulfamerazine—ALB—Hemostasis—AKT1—prostate cancer	1.1e-05	0.000248	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—CREBBP—prostate cancer	1.09e-05	0.000245	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PIK3CD—prostate cancer	1.03e-05	0.000232	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—NOS3—prostate cancer	9.71e-06	0.000219	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PIK3CB—prostate cancer	8.97e-06	0.000202	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PTGS2—prostate cancer	8.89e-06	0.0002	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PTEN—prostate cancer	7.75e-06	0.000175	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—EP300—prostate cancer	7.39e-06	0.000167	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—PIK3CA—prostate cancer	5.47e-06	0.000123	CbGpPWpGaD
Sulfamerazine—ALB—Metabolism—AKT1—prostate cancer	4.47e-06	0.000101	CbGpPWpGaD
